CAR-T Cell Therapy Market
The adoption of CAR-T cell therapy in emerging markets has lagged behind that of developed economies, primarily due to the high costs and the challenge of establishing the necessary infrastructure and expertise. However, several factors are expected to boost the use of CAR-T cell therapy in these regions in the coming years. Aging populations, urbanization, and the adoption of unhealthy lifestyles are leading to a significant rise in cancer incidence in emerging economies like China, India, and Brazil. The increasing disease burden is creating a greater need for advanced cancer treatments, such as CAR-T cell therapies.